“The plasma rich in growth factors helps prevent skin aging in a safe and effective manner.”

Vitoria-Gasteiz, March 2012.- The regeneration of tissue through the application of plasma rich in growth factors is a practice well known and used successfully in fields such as the trauma or oral implantology, however, an innovative use of this enriched plasma is opening up way in the world of aesthetics. Facial Mesotherapy with plasma rich in growth factors, also called facial rejuvenation, begins to charge force as a revolutionary treatment that prevents skin aging.

Facial rejuvenation involves the application of plasma rich in growth factors in the areas of the face that you want to treat. First carried out two or three initial session, with a time of 15 days interval between each of them and then only need one or two maintenance sessions per year, depending on the patient. Facial Mesotherapy increases the quality of the skin, its luminosity and brightness, increases the production of collagen, which gets a greater hydration, a healthy and youthful appearance and feel, tone and smoothness much improved ”, points out Dr. Julián Sanz, plastic and aesthetic surgeon of the Clínica USP La Esperanza.

The reception of this treatment has been excellent, fact which is demonstrated by the growing number of patients who undergo this technique of facial rejuvenation. The fact that you applied plasma patient autologous (from his own blood) generates much tranquillity. We know that it is a secure method and that has already proved its effectiveness in different medical specialties ”, confirms Dr. Sanz.

Facial Mesotherapy is indicated for people that are starting to have the first signs of aging in the skin, people from the age of 40 who want to curb those first signs, and is also indicated for people with ages from 60 years where ageing is more advanced and is intended to improve and recover this skin which is in worst condition ”pointed out the specialist. In addition, is a treatment more affordable than other therapeutic alternatives such as lasers or the peeling chemical ”, qualifies.

Preliminary studies

In the 2008 study was conducted a first (i) of this treatment in 100 patients and healthy volunteers. 50 Of them were applied plasma rich in growth factors (in three sessions) and the other 50 hyaluronic acid (also in three sessions). The findings of the study unveiled that the degree of improvement was much higher among patients who had received plasma enriched that among those who had been hyaluronic acid (increased basal hydration in patients treated with plasma and there was a notable decrease in the values of pH registered in the Group of PRGF).

On the USP hospital group

Founded in 1998 and headquartered in Madrid, USP hospital is the first hospital private group in the Spanish market. Currently, USP hospital boasts a network of 12 hospitals and 23 health centres which assist 4,000 doctors annually serving more than two million patients. In addition, at the beginning of 2012 is expected between commissioning a new Hospital USP La Bay in El Campo de Gibraltar.

Referencia:

(i) ANITUA, e., Sanchez, M., SARABIA, r., SANZ, j., AGUIRRE, j.j. and ORIVE, g. effectiveness and safety of the PRGF (plasma rich in growth factors) in the facial skin regeneration. Test clinical randomized and controlled with hyaluronic acid. Journal of the Spanish Association of aesthetic plastic surgery. No. 12 July-December. Pp. 23-32. 2010.